Intravitreal ERT to Prevent Retinal Disease Progression in Children With CLN2
Clinical trial NCT05152914 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05152914
- Sponsor
- David L Rogers, MD
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-01
- Primary completion
- 2026-03-04
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.